36-Month Effectiveness of Ab-Interno Canaloplasty Standalone versus Combined with Cataract Surgery for the Treatment of Open-Angle Glaucoma

Gallardo, Mark J

doi:10.1016/j.ogla.2022.02.007

Cited by 12 publications

(17 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 10 A subsequent report of outcomes at 36 months (44 eyes of 44 patients) confirmed the stability of IOP (baseline=20.5 mmHg; 12, 24, 36 months=13.3, 13.1, and 13.3 mmHg, respectively) and medication use (baseline=2.8; 12, 24, 36 months=1.1, 1.0, and 1.3, respectively). 11 Ondrejka et al reported 36-month outcomes for ab interno canaloplasty using the OSS or its predecessor, VISCO360, in a series of 206 eyes of 130 patients. Pre-operative baseline IOP was 21.1 mmHg on an average of 2.0 medications, which was reduced to an average of 15.3 mmHg on slightly less than 1 medication through the 36-month follow-up period.…”

Section: Discussionmentioning

confidence: 99%

Canaloplasty and Trabeculotomy with the OMNI System in Patients with Open-Angle Glaucoma: Two-Year Results from the ROMEO Study

Williamson¹,

Vold²,

Campbell³

et al. 2023

OPTH

View full text Add to dashboard Cite

Purpose To provide extended safety and effectiveness follow-up for eyes treated with circumferential canaloplasty and trabeculotomy (CP+TR) that were included in the 12-month ROMEO study. Setting Seven multi-subspecialty ophthalmology practices located in 6 states (Arkansas, California, Kansas, Louisiana, Missouri, and New York). Design Retrospective, multicenter, IRB approved. Subjects Eligible eyes had mild–moderate glaucoma and were treated with CP+TR with cataract surgery or as a standalone intervention. Methods Main outcome measures were mean IOP, mean number of ocular hypotensive medications, mean change in number of medications, proportion of patients with a ≥20% reduction in IOP or with IOP ≤18 mmHg, and proportion of patients medication free. Safety outcomes were adverse events and secondary surgical interventions (SSI). Results Eight surgeons at 7 centers contributed 72 patients stratified by pre-operative intraocular pressure (IOP); >18 mmHg (Grp1), ≤18 mmHg (Grp2). Mean follow-up of 2.1 years (min 1.4, max 3.5). 2-year IOP (SD) was 15.6 mmHg (−6.1 mmHg, −28% from baseline) on 1.4 medications (−0.9, −39%) for Grp1 with cataract surgery; 14.7 mmHg (−7.4 mmHg, −33% from baseline) on 1.6 medications (−0.7, −15%) for Grp1 standalone, 13.7 mmHg (−0.6 mmHg, −4.2%) on 1.2 medications (−0.8, −35%) for Grp2 with cataract surgery, 13.3 mmHg (−2.3 mmHg, −14.7%) on 1.2 medications (−1.0, −46%) for Grp2 standalone. The proportion of patients at 2 years with either a ≥20% IOP reduction or IOP between 6 and 18 mmHg and no increase in medication or SSI was 75% (54 of 72, 95% CI 69.9%, 80.1%). One-third of patients (24 of 72) were medication free whereas 9 of 72 were pre-surgical. No device-related adverse events during extended follow-up; 6 eyes (8.3%) required additional surgical or laser intervention for IOP control after 12 months. Conclusion CP+TR provides effective IOP control that is sustained for 2 years or more.

show abstract

Section: Discussionmentioning

confidence: 99%

Canaloplasty and Trabeculotomy with the OMNI System in Patients with Open-Angle Glaucoma: Two-Year Results from the ROMEO Study

Williamson¹,

Vold²,

Campbell³

et al. 2023

OPTH

View full text Add to dashboard Cite

show abstract

“…96 In adition, the study found no significant difference in surgical outcomes between phakic and pseudophakic eyes. 96 Outcome data regarding STREAMLINE and iPrime are currently lacking, given their recent release.…”

Section: Ab Interno Canaloplastymentioning

confidence: 75%

“…IOP spikes, microhyphema, hyphema, and mild AC inflammation were reported as complications in a minority of patients who underwent ABiC, irrespective of the devices used during the procedure. [96][97][98]…”

Section: Ab Interno Canaloplastymentioning

confidence: 99%

Minimally Invasive Glaucoma Surgery

Gallo Afflitto,

Swaminathan

2023

International Ophthalmology Clinics

View full text Add to dashboard Cite

“…In the retrospective study by Liu et al[83], 1 eye (1.4%) required an anterior chamber washout for hyphema, 6 eyes (8.1%) required a reoperation within 3 months for unresolved IOP spikes, and 11 patients (18.6%) had BCVA loss >3 lines. Regarding AbiC complications, one retrospective study of 81 eyes that had AbiC surgery with the iTrack reported the following complications: microhyphema (12.3%), hyphema (3.7%), and IOP spike (3.7%) 7 …”

Section: Complications Of Goniotomymentioning

confidence: 99%